FMR LLC 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:28 am Sale | 2024-02-08 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 3,963,417 6.617% | -429,814 (-9.78%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 4,393,231 9.010% | -1,752,187 (-28.51%) | Filing |
| 2022-08-10 08:10 am Purchase | 2022-08-09 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 6,145,418 12.644% | 2,672,847 (+76.97%) | Filing |
| 2022-06-10 11:04 am Sale | 2022-06-09 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 3,472,571 9.600% | -1,933,278 (-35.76%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 5,405,849 14.999% | 83,693 (+1.57%) | Filing |
| 2021-02-08 10:29 am Sale | 2021-02-05 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 5,322,156 15.000% | -10,545 (-0.20%) | Filing |
| 2020-07-10 11:38 am Purchase | 2020-07-09 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 5,332,701 14.999% | 5,332,701 (New Position) | Filing |